3 news items
Enlivex Announces Topline Results Of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
ENLV
11 Apr 24
excited about Allocetra's™ novel approach, using a first-in-class innovative cell therapy to explore the treatment of patients with acute
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
ENLV
11 Apr 24
very excited about Allocetra's™ novel approach, using a first-in-class innovative cell therapy to explore the treatment of patients with acute
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ENLV
UMAC
22 Mar 24
update. Enlivex presents a compelling investment opportunity in the biopharmaceutical sector with its innovative approach to treating life
- Prev
- 1
- Next